- Staat
- MS
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 07.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 05.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Death
Symptomtext
PATIENT BEGAN HAVING CHEST PAIN DAY AFTER SHOT 10/5/22 AND PRESENTED TO ER. PATIENT PASSED AWAY AT HOSPITAL
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- UNKNOWN TO PHARMACY AT TIME , HOSPITAL WOULD HAVE
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- HYPERTENSION, DYSLIPIDEMIA, GERD
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE ON FILE
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 16.02.2023
- Impfdatum
- 16.02.2023
- Beginn
- 16.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Syncope
Symptomtext
After patient had received all of the vaccines she had fainted while being held by the social worker. She woke up within a minute of fainting and then was given apple juice and crackers to help get her feeling better. We also gave her an ice pack for the back of her neck. Patient was also very anxious to receive vaccines before we had even started.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 16.01.2023
- Beginn
- 16.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest pain
Chills
Feeling cold
Headache
Hypersensitivity
Hypertension
Immediate post-injection reaction
Lip swelling
Tremor
Symptomtext
The patient received pneumovax23(lot #u034712 exp 30/jul/23) and then right after she got an allergy reaction( lips swelled up and chest pain and then started shaking and feeling cold then left side headache). However she was conscious and was talking normally. As soon as she had the reaction I gave her 50mg benadryl and then 2 tabs of acetamenophen (325mg) instructed by her doctor. After taking benadryl chest pain got a little better, but her headache and a chill didn't go away. We called 911 and they came and checked her. Since her blood pressure was a little high and had a headache and a chill she was sent to ER. She said that she will follow up with us. She has allergy to aspirin, NSAID and sulfa, but never had any reaction to vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Knee problem
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- none
- Allergien
- aspirin, NSAID, Sulfa
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 17.10.2022
- Impfdatum
- 13.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Palpitations
Peripheral swelling
Symptomtext
Palpitations along with swelling and redness to Right arm but no pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, Hypercholesterolemia, Diverticulosis
- Andere Medikamente
- Allopurinol 100mg, Lovastatin 40mg, Maxzide -25
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- F
- Eingang
- 16.06.2022
- Impfdatum
- 26.05.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Injected limb mobility decreased
Pyrexia
Vaccination site erythema
Vaccination site pruritus
Vaccination site swelling
Wrong technique in product usage process
Symptomtext
Caller is a patient who reported receiving PNEUMOVAX 23 vaccine on 26MAY2022 and reports that 4 hours after administration, she experienced reaction to the vaccine which included redness, itching and swollen arm.; Caller is a patient who reported receiving PNEUMOVAX 23 vaccine on 26MAY2022 and reports that 4 hours after administration, she experienced reaction to the vaccine which included redness, itching and swollen arm.; swollen arm. Some symtomps went down all the way to the elbow; Patient's body temperature was "fine" at 97.7F but experienced fever and chills.; Patient's body temperature was "fine" at 97.7F but experienced fever and chills.; This spontaneous report was received from a female consumer of unknown age referring to herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date (reported as in the past), she received a dose of pneumococcal vaccine conj 7V (CRM197) (PREVNAR) without experienced any symptom; and 2 doses of tozinameran (PFIZER BIONTECH COVID-19 VACCINE) (also reported as Pfizer's COVID-19 vaccine) that cause a little soreness but no other issue. On 26-MAY-2022, the patient was vaccinated with 1 dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (valid lot #U034712, expiration date: 30-JUL-2023) in an arm (unspecified) (also reported as ''too shallow'' administration) (strength and route of administration were not provided) as routine vaccination. Then, on the same date, after 4 hours of the administration of the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), the subject experienced a reaction to the vaccine which included redness (vaccination site erythema), itching (vaccination site pruritus) and swollen arm (vaccination site swelling). Some symptoms traveled down to the elbow and she "could not move her arm". Furthermore, it was reported that her body temperature was "fine" at 97.7 Fahrenheit (F) but experienced fever (pyrexia) and chills. Consequently, the patient's nurse advised her to took paracetamol (TYLENOL), diphenhydramine (BENADRYL) and use ice packs to help to alleviate or improve some symptoms related to itching, however not all the symptoms went away. At the reporting time, the subject was recovering from all the events. The causality assessment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) regarding the events vaccination site erythema, vaccination site pruritus and vaccination site swelling, was considered as related, and regarding the events pyrexia and chills the causality was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 29.04.2023
- Impfdatum
- 22.04.2023
- Beginn
- 25.04.2023
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Full blood count abnormal
Injection site erythema
Platelet count decreased
Symptomtext
Pt reported a red circle 3 inches in diameter at the injection site that appeared 3 days after administration. Pt also stated that he had laboratory results that included a low platelet count value reportedly around 100,000 on 4/25/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- CBC drawn on 4/25/2023 reported platelet count 100,000 from patient
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 03.04.2023
- Impfdatum
- 29.03.2023
- Beginn
- 30.03.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pyrexia
Symptomtext
Patient has been battling recurring fevers since the day after vaccine up until today (3/29/23 - 4/3/23). His whole arm is red. Parents took him to his PCP today and he began Orapred therapy for 5 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Sinus infection
- Vorgeschichte
- Frequent pneumonia infections
- Andere Medikamente
- Zyrtec, Symbicort, Azelastine, Afrin, Florastor
- Allergien
- Amoxicillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 25.03.2023
- Impfdatum
- 22.03.2023
- Beginn
- 23.03.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Pt called pharmacy 2 days later complaining of swollen, warm to touch, painful arm at the injection site. Pt went to doctor's office to get it checked out.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DIABETES
- Andere Medikamente
- METFORMIN, IBUPROFEN, TIZANIDINE, GABAPENTIN, FLONASE, TRAMADOL
- Allergien
- MORPHINE, SULFA, LATEX
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- M
- Eingang
- 02.12.2022
- Impfdatum
- 29.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Influenza virus test negative
Malaise
Pain
Rash
SARS-CoV-2 test negative
Symptomtext
generalized rash, not feeling well after getting pneumonia 23 vaccine, generalized body aches (5 days), neg covid & neg flu, rapid test, Benadryl (Hx lyme disease) and medrol dose pack ordered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- Rapid covid (-) Rapid Flu (-)
- Aktuelle Erkrankungen
- Hx Lyme Disease
- Vorgeschichte
- PCN - Allergy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 04.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Chills
Injection site erythema
Injection site pain
Injection site swelling
Malaise
Symptomtext
Patient reported chills, rigors, malaise, weakness, and redness surrounding injection site starting approx 24 hours after administration. Patient reported the injection site was painful, swollen, and the redness was spreading. She was seen at urgent care 11/2/22 and prescribed keflex. Redness continued to spread. She was seen in PCP office 11/4/22 and prescribed bactrim.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- depressive disorder gastroesophageal reflux disease hyperlipidemia hypothyroidism irritable bowel syndrome seasonal allergy
- Andere Medikamente
- acyclovir atorvastatin bupropion HCl Caltrate clobetasol clotrimazole-betamethasone finasteride flaxseed oil fluconazole hyoscyamine sulfate levothyroxine meloxicam minoxidil Premarin PreserVision AREDS-2 Probiotic triamcinolone-dimethicone
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 16.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site oedema
Injection site swelling
Injection site warmth
Pain
Symptomtext
PT INJECTION SITE BECAME WARM AND SWOLLEN, TOOK ONE DOSE OF BENADRYL, TRAVELLED DOWN TOWARD INSIDE OF ARM. CURRENTLY APPEARED FLUID FILLED AND RED/SWOLLEN ENTIRE LEFT INNER ARM TO JUST BELOW THE ELBOW WHERE SWELLING WAS THE WORST. PT C/O SOME ACHINESS AND SWOLLEN AREA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- HBP, BILE ACID MALABSORPTION, DIVERTICULOSIS
- Andere Medikamente
- ALPRAZOLAM, LISINOPRIL 20 MG, ATENOLOL 25MG, ESTRADIOL 1MG , OXYBUTYNIN ER 10 MG, TRAMADOL 50MG, IBUPROFEN, ONE-DAY WOMAN'S MVI , VIT B COMPLEX, VIT A K, ASTEPRO
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 15.10.2022
- Impfdatum
- 11.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 26.05.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Peripheral swelling
Vomiting
Symptomtext
Patient reports dizziness, vomiting, very swollen left arm, went to hospital ER and was treated but she doesn't know with what.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- high cholesterol
- Andere Medikamente
- Lipitor, multivitamin
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 25.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Injection site swelling
Rash
Symptomtext
Site: Itching at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: PATIENT STATED THAT ARM ITCHED AND HAS SMALL BUMPS ON ARM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Discomfort
Dizziness
Erythema
Mass
Pain
Pyrexia
Symptomtext
Patient reports pain the night of the injection and lump and fever, next day was dizzy, low grade fever and redness noted. patient continues to have redness and a few lumps on the arm and has been taking coricidin cold and flu and ibuprofen to help with the discomfort.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Allergic rhinitis, diffuse cystic mastopathy, esophageal reflux, moderate persistent asthma in adult without complication, essential hypertension, decreased renal function, malignant neoplasm of upper-outer quadrant of left breast in female, estrogen receptor positive, obesity, diaphragmatic hernia, intestinal disaccharidase deficiencies and disaccharide malabsorption
- Andere Medikamente
- Herbals Clear Lungs, Aloe Vera Leaf Powder, Protonix, albuterol inhaler, Letrozole, kenalog 0.1% cream, symbicort inhaler, acetic acid 2% otic solution, sudafed, nexium, losartan, hydrochlorothiazide, B Complex, Vitamin E liquid, arnica Liq
- Allergien
- Penicillin, Chlorhexidine Gluconate, milk/dairy products, scopolamine, adhesives, nasocort, paroex, red dye, sulfa drugs
- Vorherige Impfungen
- per patient reports has a reaction with a previous dose of pneumonia vaccine, wanted it anyway
- Staat
- PA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 15.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cellulitis
Injection site erythema
Injection site inflammation
Symptomtext
PATIENT COMPLAINS OF REDNESS AND INFLAMATION AT INJECTION SITE AND PROGRESSING DOWN ARM STARTING THE DAY AFTER INJECTION
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- WALK-IN PROVIDER SUSPECTS CELLULITIS AND PRESCRIBED CEPHALEXIN
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CHRONIC LYMES DISEASE
- Andere Medikamente
- -
- Allergien
- PENICILLINS AND CODIENE
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 01.09.2022
- Impfdatum
- 27.08.2022
- Beginn
- 27.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pain
Pyrexia
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Fever-Medium, Additional Details: Patient taking Ibuprofen for fever and pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 22.08.2022
- Impfdatum
- 17.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site pain
Symptomtext
Injection site was red and painful and spread throughout bicep and lasted for three days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- hyperlipidemia, heart murmur
- Andere Medikamente
- Patient does not take any medications, supplements or herbal remedies.
- Allergien
- lactose and lipitor
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Headache
Swelling
Tenderness
Vaccination site swelling
Symptomtext
Patient states the day of the vaccine she developed a headache and noticed swelling below where the vaccines was given. The next day the swelling was worse and seemed to have moved to her under arm area and side of breast on right side (same side vaccine was given). Since then the swelling has continued to decrease and improve. She also experienced some tenderness in the areas that were swollen which has also improved. On the night of 07/26/2022 she reported worsening of her headache and a spike in her blood pressure overnight. She states diastolic pressure was 101. She then measured with a wrist blood pressure monitor in the morning which showed 141/71. Since the headache as resolved and her blood pressure has lowed she is not seeking medical care at this time but will if she notices a similar spike again. Swelling also has continued to improve, patient has been applying ice. States she prefers not to take NSAIDs if she can avoid it. Patient requested a report be filed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown - none reported on vaccine questionnaire
- Vorgeschichte
- Unknown - none reported on vaccine questionnaire
- Andere Medikamente
- Unknown
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Induration
Pruritus
Skin warm
Swelling
Symptomtext
she had developed itching, swelling, induration and skin warm to the touch.; she had developed itching, swelling, induration and skin warm to the touch.; she had developed itching, swelling, induration and skin warm to the touch.; she had developed itching, swelling, induration and skin warm to the touch.; patient was administered a second unnecessary dose of PNEUMOVAX 23 and the patient developed side effects; This spontaneous report has been received from a nurse referring a 67-year-old female patient. The patient's medical history, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On an unknown date in 2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 1st dose, as prophylaxis (lot number, expiration date, and route of administration were not provided). On 05-JUL-2022, the patient was vaccinated with an unnecesary second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 2nd dose, lot number U034712, expiration date: 30-JUL-2023, as prophylaxis (route of administration was not provided (extra dose administered). On 06-JUL-2022, the patient had developed itching, swelling, induration and skin warm to the touch, it was stated that the patient was the patient was seen by the healthcare provider and was treated with ketorolac tromethamine (TORADOL). The outcome of the events pruritus, swelling, induration and skin warm were not provided. The causality assesment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and pruritus, swelling, induration and skin warm was not provided. ; Sender's Comments: US-009507513-2207USA002506:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 25.04.2022
- Impfdatum
- 20.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Injection site lymphadenopathy
Lymph node pain
Lymphadenopathy
Vaccination site rash
Symptomtext
Headache, Vaccine administration site rash and Left upper extremity/Axilla, Lymph nodes tenderness, and adenopathy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Chlamydia
- Vorgeschichte
- HIV Asthma ADHD GAD PTSD
- Andere Medikamente
- Albuterol HFA, Flovent HFA, Cholecalciferol 125mcg, Ketoconazole 2%, Doxycycline 100mg, Biktarvy 500-200-25mg
- Allergien
- Marijuana -Anaphylaxis Zofran- Rash
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.10.2023
- Impfdatum
- 18.10.2023
- Beginn
- 18.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Patient was accidently administered an expired dose of PNEUMOVAX 23 on Oct 18, 2023. Product expired on Jul 30, 2023.; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 18-OCT-2023, the patient was accidently vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection (lot#: U034712, expiration date: 30-JUL-2023, once; strength, dose, and route of administration were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.09.2023
- Impfdatum
- 07.09.2023
- Beginn
- 07.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; patient who received an expired dose of PNEUMOVAX 23 (pre-filled syringe) with no prior TEs.; This spontaneous report was received from a licensed practical nurse (LPN) concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-SEP-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, 0.5 milliliter, lot #U034712, expiration date: 30-JUL-2023, administered as prophylaxis (strength, and route of administration were not provided) (Expired product administered). It was reported that the vaccine did not have any prior temperature excursions. No symptoms or additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.09.2023
- Impfdatum
- 29.08.2023
- Beginn
- 29.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; inadvertent administration of expired PNEUMOVAX 23 to a patient; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 29-AUG-2023, the patient was vaccinated inadvertently with expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5ml/once, lot #U034712, expiration date: 30-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). There were no adverse events reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- F
- Eingang
- 10.08.2023
- Impfdatum
- 02.08.2023
- Beginn
- 02.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse issues or side effects were reported surrounding the administration of the expired; dose of PNEUMOVAX 23 that expired on 07/30/2023; This spontaneous report was received from a medical assistant referring to a 20-year-old female patient. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 02-AUG-2023, the patient was vinadvertently accinated with pan expired neumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5mL via injection in the right deltoid, lot # U034712 with expiration date 30-JUL-2023, for prophylaxis (strength and route of administration were not reported). The facility recognized the incident on the same date. The vaccine did not experience any temperature excursions. No adverse issues or side effects were reported surrounding the administration of the expired vaccine. The person who administered the vaccine was an experienced medication aide and the product had been disposed of and was not available for retrieval.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 07.08.2023
- Impfdatum
- 04.08.2023
- Beginn
- 04.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
As I was documenting inputting vaccine information in patients chart I realized vaccine had expired 4 days ago. Patient had already left office and I reached out to leadership right away to let them know and informed the provider about vaccine expiration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Bacteriuria, Benign prostatic hyperplasia with lower urinary tract symptoms, hyperlipidemia,
- Vorgeschichte
- Benign prostatic hyperplasia with lower urinary tract symptoms, hyperlipidemia
- Andere Medikamente
- Ciprofloxacin 500mg finasteride 5 mg Fluorouracil 5%cream meclizine 25mg pravastatin 10 mg Tamsulosin 0.4mg
- Allergien
- Anesthetics
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 13.06.2023
- Impfdatum
- 09.01.2023
- Beginn
- 09.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
PPSV23 given outside age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 13.06.2023
- Impfdatum
- 28.01.2023
- Beginn
- 28.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
PPSV23 given outside age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,1
- Geschlecht
- M
- Eingang
- 12.06.2023
- Impfdatum
- 02.06.2023
- Beginn
- 02.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No side effects reported; HCP reporting administration of PNEUMVAX 23 to a 6 week and 3 day old patient. No side effects reported. See request cases 02400107 and 02400128. No additional AE/PQC.; This spontaneous report has been received from an other health professional referring to a 6 weeks and 3 day old male patient. The patient's pertinent medical history, concomitant medications and drug allergies/reactions were not provided. On 02-JUN-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # U034712, expiration date 30-JUL-2023 for prophylaxis (strength, dose and anatomical location were not provided) (product administered to patient of inappropriate age). No side effects reported. No additional AE/PQC.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 12.05.2023
- Impfdatum
- 10.10.2022
- Beginn
- 12.05.2023
- Tage bis Beginn
- 214,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient received wrong vaccine for age group. No known reactions to vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 06.03.2023
- Impfdatum
- 03.03.2023
- Beginn
- 03.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site cellulitis
Symptomtext
cellulitis, appears to be at flu vaccine site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site cellulitis
- Hospital-Tage
- -
- Labordaten
- nn/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hx of rhabdomyosarcoma, duplicate renal collecting system on right
- Andere Medikamente
- unknown but possibly melatonin
- Allergien
- late, adhesive/tape, vanco
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 17.02.2023
- Impfdatum
- -
- Beginn
- 09.02.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; LPN calling for stability evaluation of vaccines with multiple TEs dating back to 03FEB2023. Caller reports that vaccines were administered. No additional AEs. no PQCs reported.; This spontaneous report was received from a nurse concerning to a 51-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 09-FEB-2023, the patient was vaccinated with improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml/once m (lot # U034712 has been verified to be a valid lot, expiration date 30-JUL-2023) (strength and anatomical location was not provided) for prophylaxis (Product storage error). There were multiple temperature excursions dating back to 03-FEB-2023. No additional adverse event was reported. This is one of multiple reports received from the same reporter. ; Sender's Comments: US-009507513-2302USA004298: US-009507513-2302USA004511: US-009507513-2302USA004369: US-009507513-2302USA004361:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- -
- Geschlecht
- M
- Eingang
- 15.02.2023
- Impfdatum
- 06.02.2023
- Beginn
- 06.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Vaccine administered on 06FEB2023 while improperly stored during temperature excursion.; LPN calling for stability evaluation of vaccines with multiple TEs dating back to 03FEB2023. Caller reports that vaccines were administered. No additional AEs. no PQCs reported.; This spontaneous report was received from a nurse and refers to a 71-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 06-FEB-2023, the patient was vaccinated with improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 ml/once, lot # U034712, expiration date 30-JUL-2023, strength was not provided) for prophylaxis (Product storage error). There were multiple temperature excursions dating back to 03-FEB-2023. No additional adverse event was reported. This is one of multiple reports received from the same reporter. ; Sender's Comments: US-009507513-2302USA004511: US-009507513-2302USA004361: US-009507513-2302USA004369: US-009507513-2302USA004552:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Wrong product administered
Symptomtext
Patient presented for routine follow up visit with her PCP. Patient was now age 65 and doctor ordered a Prevnar 13 vaccination for patient. Nurse administered a PPSV 23 vaccine instead. Patient had a previous dose of PPSV 23 on 09/14/2018. No adverse reactions noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- athropathy of lumbar facet joing, DMII with polyneuropathy, peripheral neuropathy, hypothyroidism,hyperlipidemia, chronic kidney disease, anemia, osteopenia, vit d deficiency, polyclonal gammopathy, migraines, asthma, sjogrens syndrome, urge incontinence, history of breast cancer, obesity, constipation, chest pain, syncope
- Andere Medikamente
- ferrous sulfate, pravastatin, sumatriptan, senna S, levothyroxine, fluticasone, calcium with vit d, lisinopril, gabapentin
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 13.01.2023
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No additional AE reported; Caller reports a 2 year old male patient received PNEUMOVAX 23 instead of PREVNAR 13; This spontaneous report was received from a medical assistant referring to a 2-year-old male patient. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies was not reported. On 05-JUL-2022, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot# U034712, expiration date upon internal review was established as 30-JUL-2023, strength and route were not reported) for prophylaxis instead of pneumococcal conjugate vaccine (13-valent) (PREVNAR 13) (wrong product administered). No previous doses were vaccinated. No additional adverse event (AE) details available. No additional AE reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- 28.07.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; Nurse calling for TE evaluation in TE case 02216792 reports 1 dose of PNEUMOVAX 23 administered to 1 patient. Names of vaccines involved (including lot/exp) PNEUMOVAX 23 PFS U034712 7/30/2023 ? Temperature 0.6C ? Time fra; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 28-JUL-2022, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U034712, expiration date: 30-JUL-2023 (strength, route of administration, and indication were not provided) administered for prophylaxis (Product storage error). Administered dose of vaccine experienced the temperature excursion of 0.6 degrees Celsius for 23 hours. There was no previous temperature excursion. There was no adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.08.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Syringe issue
Symptomtext
No additional AE; something is wrong at the base of the syringe where it meets the hub which looks offset a little bit. Fluid came out bottom of hub (PFS); he is unsure how much was received by patient.; This spontaneous report was received from a nurse, concerning a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions and concomitant therapies was not provided. On 21-JUL-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) prefilled syringe, at a dose of 0.5 milliliter, lot #U034712, expiration date: 30-JUL-2023 (strength, route of administration and anatomical location were not provided) administered for prophylaxis. The reporter stated that while giving the injection, something was wrong at the base of the syringe where it met the hub and that the hub looked offset a little bit (syringe issue); fluid came out bottom of hub as he began to push, and he was unsure how much was received by patient (Incorrect dose administered). The reporter stated he had been a nurse for 8 years and this was the first time he had seen this issue. No additional adverse event was reported (no adverse event). Complaint Description Detail: Nurse reporting an AE. Caller stated that fluid came out bottom of hub (PFS) as he began to push and he is unsure how much was received by patient. Caller stated something is wrong at the base of the syringe where it meets the hub and that the hub looks offset a little bit. Per caller, this is not an issue with the connection between needle and hub. Caller stated he has been a nurse for 8 years and this is the first time he has seen this issue. No additional AE/PQC. QUESTIONS SECTION: IF REPORTED: PQC Prefilled Syringe: PQC Prefilled Syringe: Syringe Needle Defects Dull Bent Damaged Missing Syringe Needle Hub Defects Broken Wrong Color Syringe Needle Sheath Cover Defects Damaged Missing, Dislodged (High Risk) QUESTIONS SECTION: - What are the lot number(s) on the product/carton? U034712, 30-JUL-2023 NOTE: This is needed to identify the needle supplied with the kit. - Please identify which part of the syringe needle is affected NA. NO NEEDLE ISSUE. HUB ISSUE. - Please provide a detailed description of the complaint defect. HUB IS OFFSET TO THE RIGHT. IF I TRY TO WIGGLE IT, IT DOES WIGGLE A LITTLE BIT. FIRST TIME SEEN THIS IN 8 YEARS - Under what situation was this defect noticed: (select one) f the syringe needle is not integrated into the syringe: - Prior to removing the needle sheath? NA - After remove the needle sheath? NA - Prior to attaching the needle to the body of the syringe? NA - While attaching the needle to the syringe? NA - While giving the injection? YES PRODUCT CAME OUT AT THE HUB WHERE THE HUB MEETS THE HAMBER THAT HOLDS THE PRODUCT WHEN CALLER BEGAN PUSHING THE PRODUCT. - After the injection was given? NA - If Syringe needle is integrated into the body of the syringe: - Prior to removing the needle sheath? NA - After remove the needle sheath? NA - While giving the injection? NA - After the injection was given? NA - If the complaint is for a dull needle: - Did you/the patient allow at least one minute for the disinfectant (e.g. alcohol) to dry on your/the patient' s skin before inserting the needle? NA - Did you/the patient use an alcohol swab on the syringe needle? NA NOTE: An alcohol swab should not be used on the syringe needle as it removes the silicone - Did you/the patient use a "slightly" different injection site than the last injection? NA - Have you/the patient injected yourself/herself at this injection site before? NA - Did you/the patient insert the needle into the body at an angle of 45 to 90 ? NA - Did you/the patient draw blood into the syringe and need to reposition the needle without removing from the skin? NA - How many times did you/the patient try to inject the syringe? inject the syringe once) NA - Was the product dropped? NO - Was the syringe tray intact and undamaged on receipt? YES - If no, describe damage. - If the product came with a cellophane cover, was the cellophane covering the syringe tray intact and completely sealed? *See below. NA - If no, describe damage - Was the syringe carton damaged prior to use? (i.e. crushed, ripped, unglued) NA - If yes, describe - Was the product administered or exposed to patient's bodily fluids(i. e. biohazardous)? YES - If complaint sample is not/cannot be returned, please provide reason: - *If photos are available, ask the customer to send them Retrieval Information: Obtain product (& tray if possible). Ensure enough absorbent material is provided to prevent breakage. NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. Sample Tracking Number: User's Experience: Repeat User Insertion Difficulty: Not Applicable Insertion Difficulty Details: Not Applicable Doubt About Presence: Not Applicable Doubt Details: Not Applicable Migration: Not Applicable Migration Details: Not Applicable Removal Problem: Not Applicable Removal Problem Details: Not Applicable 21-JUL-2022 16:30 PM: Attachment added. 21-JUL-2022 16:30 PM: Attachment added. 21-JUL-2022 16:30 PM: Case closed in error, re opened to place in submitted state while waiting for product retrieval. Task added. 21-JUL-2022 16:30 PM: Attachment added. 21-JUL-2022 16:30 PM: Waiting for Retrieval Site from Quality--See attachments 22-JUL-2022: Second person reviewed. 22-JUL-2022 12:30: Attachment added. 25-JUL-2022: Received & Attached failure-Missing info added below 22-JUL-2022T12: 08:00-04:00 Complaint Sample description: <not set> Complaint Description Summary: caller is reporting that the hub looks offset and wiggles a little bit, and also stated that fluid came out bottom of hub (PFS) as he began to push.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 67,0
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 19.10.2020
- Beginn
- 29.06.2022
- Tage bis Beginn
- 618,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
The patient did not develope side effects; The patient was administered a second unnecessary dose of PNEUMOVAX 23; This spontaneous report has been received from a registered nurse (RN) concerning to a 67-year-old patient. The patient's concurrent conditions, medical history, drug/allergy reactions, and concomitant therapies, were not reported. On 19-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose/route/frequency of administration, lot number, and expiration date were not reported) for prophylaxis. On 29-JUN-2022, the patient was vaccinated with an unnecessary second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (extra dose administered) (lot number U034712 with expiration date 30-JUL-2023) (strength, dose/route/frequency of administration date were not reported) for prophylaxis. The patient did not develop side effects. No additional adverse events (AEs) were reported (no adverse event). This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2207USA002428:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Peripheral swelling
Skin abrasion
Swelling
Symptomtext
Patient was given a Pneumovax 23 on 07/11/2022. Patient called the next day and reported upper arm swelling, redness, warmth, and swelling under her left armpit. Range of motion of the arm was not affected nor did she have a systemic symptoms. PCP was notified immediately and patient was instructed to use Tylenol, Benadryl, ice pack, and call back for any worsening symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Peripheral swelling
Skin warm
Symptomtext
Patient was given an injection by a nurse on 07/11/2022. Patient called the next day and reported redness, swelling of the upper arm, and warmth. Patient did not exhibit systemic symptoms and the range of motion of the left arm was not affected. PCP notified and patient was instructed to use Benadryl, ice therapy, and Tylenol if needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 27.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported.; at least one dose of PNEUMOVAX 23 was administered following a temperature excursion.; This spontaneous report has been received from a nurse referring a patient of a unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 27-JUN-2022, the patient was vaccinated with an improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 1 syringes, lot number U034712, expiration date: 30-JUL-2023, as prophylaxis (strength, vaccination scheme, anatomical location and route of administration were not provided) following a temperature excursion of 58.3 degrees Fahrenheit (F) for 8 hours (product storage error), there was stated that no previous temperature excursion occurred. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, current condition, previous drug reaction or allergy, and concomitant medication were not reported. On 07-JUN-2022, the patient was vaccinated with improperly stored pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (strength, anatomical site of vaccination were not reported, 0.5 ml, lot number U034712, expiration date reported and validated as 30-Jul-2023) intramuscular (IM) for prophylaxis (product storage error). The vaccine was exposed to the temperature excursions: 34.2 degrees Fahrenheit for 12 hours. There was no previous temperature excursion. No additional adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.06.2022
- Impfdatum
- -
- Beginn
- 03.06.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported; Caller reports vaccine administered after temperature excursion.; This spontaneous report was received from a source, from a Medical Assistant reporter. With patient initials and name, unknown information (no date of birth, nationality, age or gender or patient ID. The patient medical history, current conditions, historical drugs and drug reactions or allergies and concomitants therapies were not mentioned. On 09-JUN-2022 at 04:14pm it was information received that described according to the caller that a vaccine was administered after temperature excursion. No other information provided. No additional AEs or PQC reported. Therapy information: Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) lot# U034712 validated, expiration date: 7/30/2023, dose 0.5 ml, route of administration intramuscular, temperature 34.2F, time frame 12 hours, no previous temperature excursion. Indication for prophylaxis. Unknown start date, strength, formulation, and frequency. There were no adverse events reported related to the situation described. No lab data, other medications and treatments reported. The action taken, dechallenge, rechallenge and causalities were not reported. No outcome, reported causality, cross reference, serious criteria or downgrade stament were described.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.06.2022
- Impfdatum
- 04.06.2022
- Beginn
- 04.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported.; Caller reports vaccine administered after temperature excursion.; This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medication was not provided. On 04-JUN-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U034712 with expiration date: 30-JUL-2023, 0.5 milliliter, strength unknown) intramuscularly for prophylaxis after temperature excursion (product storage error). No additional adverse events (AEs) or product quality complaints (PQC) reported. Administered dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) experienced the temperature excursion below 34.2 Fahrenheit degrees (F) for 12 hours. No previous temperature excursions reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- 09.06.2022
- Beginn
- 09.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported.; Caller reports vaccine administered after temperature excursion. No other information provided. No additional AEs or PQC reported. ? Names of vaccines involved (including lot/exp) PNEUMOVAX 23 U034712 7/30/2023 ? Temperatu; This spontaneous report was received from a medical assistance, referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 09-JUN-2022, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 ml im, lot #U034712, expiration date: 30-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided). The administered doses of the vaccines were stored with the temperature of 34.2 degrees Fahrenheit, the time frame was 12 hours. There was no previous temperature excursion. No adverse effect reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported; Caller reports vaccine administered after temperature excursion. No other information provided. No additional AEs or PQC reported. ? Names of vaccines involved (including lot/exp) PNEUMOVAX 23 U034712 7/30/2023 ? Temperatu; This spontaneous report was received from a medical assistance, referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 07-JUN-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 milliliter, lot #U034712, expiration date: 30-JUL-2023, administered intramuscularly for prophylaxis (strength was not provided). The administered dose of the vaccine was stored with the temperature of 34.2 degrees Fahrenheit, the time frame was 12 hours. There was no previous temperature excursion. No adverse effect reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- 02.06.2022
- Beginn
- 02.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AEs or PQC reported.; Caller reports vaccine administered after temperature excursion. No other information provided. No additional AEs or PQC reported. Include in the Description (cut and paste with responses) details of the improperly stored temperature excursion.; This spontaneous report was received from a medical assistance and referred to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 02-JUN-2022, the patient was vaccinated with an improperly dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 milliliter, lot #U034712, expiration date: 30-JUL-2023, administered intramuscularly for prophylaxis (strength was not provided)(product storage error). The administered dose of the vaccine was stored with the temperature of 34.2 degrees Fahrenheit, the time frame was 12 hours. There was no previous temperature excursion. No adverse effect reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.06.2022
- Impfdatum
- 04.06.2022
- Beginn
- 04.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no additional AE; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Concomitant medications, pertinent medical history, and drug reactions/allergies were not reported. On 04-JUN-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter, lot #U034712, expiration date: 30-JUL-2023, administered intramuscularly for prophylaxis (strength was not provided) after a temperature excursion at 34.2 F for 12 hours (product storage error). There was no previous temperature excursion. No other information or additional adverse event (AE) was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 01.06.2022
- Beginn
- 08.06.2022
- Tage bis Beginn
- 7,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Erythema
Feeling hot
Swelling
Symptomtext
Patient received vaccine on 6/7/22 and called the office on 6/8/22 reported redness, warmth and swelling. Patient was seen in office 6/8/22 and treated with antibiotic and a dx of cellulitis was given. Follow up scheduled for 6/15/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None noted
- Vorgeschichte
- Chronic fatigue Fibromyalgia hypertension Insomnia Mixed hyperlipidemia Myalgia Synovitis Morning Stiffness of joints
- Andere Medikamente
- Avapro Pravachol Prolia Desyrel Vit D3
- Allergien
- Azithromycin
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 13.05.2022
- Beginn
- 15.05.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test
Cellulitis
Ultrasound scan
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood test
- Hospital-Tage
- -
- Labordaten
- Blood tests, ultrasound 5/16/2022
- Aktuelle Erkrankungen
- Viral syndrome
- Vorgeschichte
- Neuroendocrine cell hyperplasia of infancy
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -